Whitehawk Therapeutics, Inc. Common Stock
Symbol: WHWK (NASDAQ)
2.39
▲ (13.62%) 0.286
Company Description:
Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers.
Key Stats
- Today's Open: $3.46
- Today's High: $4.338
- Today's Low: $2.102
- Today's Volume: 94.34M
- Yesterday Close: $2.1
- Yesterday High: $2.12
- Yesterday Low: $1.98
- Yesterday Volume: 126.37K
- Last Min Volume: 0
- Last Min High: $2.386
- Last Min Low: $2.386
- Last Min VWAP: $0
Company Profile
- Name: Whitehawk Therapeutics, Inc. Common Stock
- Website: https://www.whitehawktx.com
- Listed Date: 2021-08-27
- Location: MORRISTOWN, NJ
- Market Status: Active
- CIK Number: 0001422142
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $98.97M
- Round Lot: 100
- Outstanding Shares: 47.13M
- Asset Type: CS
RECENT FILINGS FOR WHWK
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-25 | SCHEDULE 13G | View |
| 2025-08-07 | 10-Q | View |
| 2025-08-07 | 8-K | View |
| 2025-06-17 | 4 | View |
| 2025-06-17 | 4 | View |
| 2025-06-16 | 4 | View |
| 2025-06-16 | 4 | View |
| 2025-06-16 | 4 | View |
| 2025-06-16 | 4 | View |
| 2025-06-16 | 4 | View |
| 2025-06-16 | 4 | View |
| 2025-06-13 | 8-K | View |
| 2025-05-22 | UPLOAD | View |
| 2025-05-15 | SCHEDULE 13G | View |
| 2025-05-15 | SCHEDULE 13G/A | View |
| 2025-05-13 | CORRESP | View |
| 2025-05-08 | 10-Q | View |
| 2025-05-08 | 8-K | View |
| 2025-05-07 | UPLOAD | View |
| 2025-04-28 | ARS | View |